HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral administration of Euglena gracilis paramylon ameliorates chemotherapy-induced leukocytopenia and gut dysbiosis in mice.

Abstract
Euglena gracilis (EUG) is a food supplement rich in beta-glucans, which are stored in the form of granules called paramylon. We determined whether EUG improved chemotherapy-induced leukocytopenia and dysbiosis. Mice were orally administered EUG prior to gemcitabine treatment. Analyses of the blood cell count, leukocyte population in the spleen, granulocyte/macrophage-colony-stimulating factor (GM-CSF) production by splenocytes, and fecal microbiome were conducted. The recovery of total leukocytes, neutrophils, and monocytes was accelerated after a single gemcitabine treatment. A more rapid lymphocyte recovery rate was observed after four gemcitabine treatments. No difference was observed in the percentage of T, B, or myeloid cells or in the expression of Dectin-1 in the spleens of the gemcitabine and EUG/gemcitabine groups. The EUG/gemcitabine group showed an enhanced GM-CSF production by lipopolysaccharides-stimulated splenocytes. Next-generation sequencing revealed that gemcitabine-induced dysbiosis was alleviated. This study demonstrated that EUG-derived beta-glucans could act as a biological response modifier as well as prebiotics for ameliorating chemotherapy-induced adverse effects.
AuthorsYoungju Song, Hocheol Shin, Hanary Geby Jessica Sianipar, Ji Yun Park, Migi Lee, Jihye Hah, Hong Shik Park, Hyun Jeong Lee, Sukchan Lee, Hee Kang
JournalInternational journal of biological macromolecules (Int J Biol Macromol) Vol. 211 Pg. 47-56 (Jun 30 2022) ISSN: 1879-0003 [Electronic] Netherlands
PMID35490767 (Publication Type: Journal Article)
CopyrightCopyright © 2022 Elsevier B.V. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • Glucans
  • beta-Glucans
  • paramylon
  • Granulocyte-Macrophage Colony-Stimulating Factor
Topics
  • Administration, Oral
  • Animals
  • Antineoplastic Agents (adverse effects, metabolism)
  • Dysbiosis (chemically induced, drug therapy)
  • Euglena gracilis (metabolism)
  • Glucans
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Leukopenia
  • Mice
  • beta-Glucans (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: